Publications and communications of Clotilde Hoyos

Hoyos, C. (2022). L’inhibition HDAC induite par le valproate améliore la cytotoxicité directe des monocytes contre les cellules de mésothéliome pleural malin. Unpublished doctoral thesis, ULiège - Université de Liège [Gembloux Agro Bio-Tech], Gembloux, Belgium.
Jury: Willems, L. (Promotor), Jacques, P., Arnaud Scherpereel, Christophe Blanquart, Schroyen, M., ... CATALDO, D.

Hoyos, C.* , Fontaine, A.* , Jacques, J.-R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Jamakhani, M.* , Hamaïdia, M.* , & Willems, L.*. (26 April 2022). HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. Cancers, 14 (9), 2164. doi:10.3390/cancers14092164
* These authors have contributed equally to this work.

Hoyos, C. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma. Paper presented at Giga Cancer Day, Liège, Belgium.

Hoyos, C., Fontaine, A., Brossel, H., Willems, M., Jamakhani, M., Vandermeers, F., Safari, R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Mascaux, C., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma. Poster session presented at Giga Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (27 June 2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211

Hoyos, C. (26 March 2021). The contribution of hdac inhibition in therapy of malignant pleural mesothelioma. Paper presented at Séminaire du Giga-Cancer, Liège, Belgium.

Hoyos, C., Hamaïdia, M., Safari, R., & Willems, L. (28 November 2019). Les monocytes possèdent une activité cytotoxique directe envers les cellules de mésothéliome pleural malin. Poster session presented at 2n des Journées Francophones du Mésothéliome (Nantes), Nantes, France.

Hoyos, C. (19 November 2019). L'inhibition de PD-1 augmente l'activité cytotoxique des macrophages envers les cellules de mésothéliome pleural malin. Paper presented at 2e des Journées Francophones du Mésothéliome.

Abdala, A., Alvarez, I., Brossel, H., Calvinho, L., Carignano, H., Franco, L., Gazon, H., Gillissen, C., Hamaïdia, M., Hoyos, C., Jacques, J.-R., Joris, T., Laval, F., Petersen, M., Porquet, F., Porta, N., Ruiz, V., Safari, R., Suárez Archilla, G., ... Willems, L. (07 October 2019). BLV: lessons on vaccine development. Retrovirology, 2019 (16), 26. doi:10.1186/s12977-019-0488-8

Hamaïdia, M., Gazon, H., Hoyos, C., Hoffmann, G. B., Louis, R., DUYSINX, B., & Willems, L. (2019). Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1-dependent mechanism. JCI Insight, 4 (18). doi:10.1172/jci.insight.128474

Hoyos, C., Hamaïdia, M., Black, I., DUYSINX, B., LOUIS, R., & Willems, L. (28 May 2018). Immunoediting activity of macrophages against mesothelioma cells. Poster session presented at Séminaire de l'EDT-Immunologie, Liège, Belgium.

Gazon, H., Chauhan, P. S., Hamaïdia, M., Hoyos, C., Li, L., Safari, R., & Willems, L. (15 January 2018). How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response? Frontiers in Microbiology, 8, 2684. doi:10.3389/fmicb.2017.02684